老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

151.04
+1.020.68%
成交量：4.89萬
成交額：735.85萬
市值：154.06億
市盈率：22.14
高：151.22
開：150.34
低：149.85
收：150.02
52周最高：186.12
52周最低：122.14
股本：1.02億
流通股本：9,999.56萬
量比：0.69
換手率：0.05%
股息：- -
股息率：- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率：22.09%
總資產收益率：11.70%
市淨率：4.17
市盈率(LYR):32.34

資料載入中...

總覽公司新聞資訊公告
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

重要事件披露

Current report, items 2.02, 5.02, 5.03, and 9.01
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/11

超過5%披露

General statement of acquisition of beneficial ownership
2019/12/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/10/16

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/10/04

持股變動聲明

Statement of changes in beneficial ownership of securities
更多